Project Grant IL54983

This Project Grant from the National Heart, Lung and Blood Institute, part of the Department of Health and Human Services, was awarded under the Cardiovascular Diseases Research program (CFDA 93.837) to develop clinical software to support quantitative analysis and interpretation of myocardial contrast echocardiography (MCE) data. Narnar, LLC received $757,197 to create software modules that enhance MCE's ability to identify coronary microvascular dysfunction (MVD). The software will average...

This federal Project Grant award from the National Institutes of Health (NIH) Office of Research Infrastructure Programs (CFDA 93.351) provides $481,800 to East Tennessee State University (ETSU) to acquire a Vevo F2 Ultrasound Imaging System. The Vevo F2 will replace ETSU's aging Vevo 1100 ultrasound system and enhance imaging capabilities for NIH-funded cardiovascular, cancer, and vasculature research across ETSU's Quillen College of Medicine, College of Public Health, and College of Arts and...

Federal Grant Award Summary Airalux Medical, Inc. received a $306,872 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 5, 2025, through September 4, 2026. The company is developing a digitally enhanced incentive spirometer device designed to improve patient adherence to post-operative respiratory therapy and streamline clinical workflows. The device combines advanced sensors and...

The National Science Foundation (NSF) awarded a $275,000 Phase I Small Business Innovation Research (SBIR) grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to KAI TECH LLC. The funding supports the development of an advanced software system called ECG-AID for automated electrocardiogram (ECG) analysis and interpretation. The ECG-AID prototype integrates a comprehensive ECG database, Z-score-based assessments, and machine-learning techniques to enhance the...

Oregon Health & Science University (OHSU) received a $742,360 Project Grant award from the National Institutes of Health Office of the Director under the Research Infrastructure Programs (CFDA 93.351) on July 15, 2025, with a completion date of July 14, 2026. The award funds the acquisition of a VEVO F2 LAZR-X dual ultrasound-photoacoustic imaging system (FUJIFILM, VisualSonics) to support in vivo, non-invasive longitudinal imaging of small animal models. This advanced instrumentation...

This federal Project Grant award of $577,000 from the U.S. Department of Health and Human Services (HHS) Healthcare Systems Bureau was provided to the Elliot Hospital of the City of Manchester in New Hampshire under the Congressional Directives (CFDA 93.493) program. The funding will be used to upgrade the hospital's mammography imaging capabilities by replacing aging equipment with high-resolution 3D mammography technology. This upgrade will enable the hospital to take one tomographic image and...

This $783,801 Project Grant, awarded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) on September 3, 2025, supports research to demonstrate the feasibility of democratizing cardiac magnetic resonance imaging (CMR) technology for use in community family health centers. The award, which extends through May 31, 2029, funds development and implementation of an automated, push-button CMR protocol (AutoCMR) combined with...

Federal Project Grant Award Summary Massachusetts General Hospital received a $1,835,840 Project Grant award dated August 1, 2025, under the Research Infrastructure Programs (CFDA 93.351) administered by the National Institutes of Health Office of the Director. The award funds the acquisition and installation of a clinical-grade NVision Polaris C13 Polarizer, an FDA-approved instrument that enables hyperpolarized carbon-13 (C13) magnetic resonance imaging (MRI). This specialized equipment...

Sonnest Inc. received a $4,248,628 Project Grant award from the National Heart Lung and Blood Institute within the Department of Health and Human Services' National Institutes of Health to develop an innovative voltage-activated ultrasound imaging agent called Electrast. Under the Cardiovascular Diseases Research program (CFDA 93.837), Sonnest will validate Electrast's ability to selectively enhance viable, perfused myocardium without ionizing radiation. They will also complete CGMP...

This National Science Foundation (NSF) Project Grant under the Engineering program (CFDA 47.041) awarded The Methodist Hospital Research Institute in Houston, TX $248,310 to research and develop technologies and practices that enable remote physicians to collaborate with nurses at local sites to perform medical physical examinations. The key products and services to be delivered include: The project will investigate touch sensing and display technologies, interaction methodologies and designs,...